Literature DB >> 2545916

Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats.

H J Theunissen1, M Paardekooper, L J Maduro, R J Michalides, R Nusse.   

Abstract

Acquired proviruses of mouse mammary tumor virus (MMTV) in T-cell leukemias of male GR mice have rearrangements in the U3 region of their long terminal repeats (LTR). In contrast to the endogenous nonrearranged MMTV proviruses, these mutated copies are highly expressed in leukemic T cells. To investigate whether the sequence alterations in the LTR are responsible for the high expression of rearranged MMTV proviruses, we made constructs in which normal and variant LTRs drive the bacterial reporter gene chloramphenicol acetyltransferase (CAT). Two different rearranged LTRs were used, one containing a 420-base-pair (bp) deletion (L13) and another carrying a 456-bp deletion plus an 82-bp insertion (L42). These constructs were transfected into murine (GRSL) and human (MOLT-4) T-cell lines that either had or had not been treated with phorbol ester (12-O-tetradecanoylphorbol-13-acetate [TPA]). In GRSL cells, the L13-LTR-CAT construct showed transcriptional activity that was further enhanced by TPA. In MOLT-4 cells, both variant LTRs were active, but only after stimulation with TPA. In contrast, normal(N)-LTR-CAT constructs were not expressed, irrespective of TPA addition. In XC rat fibrosarcoma cells, neither normal nor variant LTRs gave rise to detectable CAT activity, either in the presence or in the absence of TPA, but dexamethasone strongly stimulated CAT activity driven by N and L42 LTRs. The L13 LTR was considerably less active, probably caused by the deletion of the distal part of the glucocorticoid responsive element. We conclude that the LTR rearrangements generate TPA responsiveness and contribute to T-cell-specific expression of MMTV variants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545916      PMCID: PMC250923          DOI: 10.1128/JVI.63.8.3466-3471.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 3.  Mammary tumor viruses.

Authors:  D H Moore; C A Long; A B Vaidya; J B Sheffield; A S Dion; E Y Lasfargues
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

Review 4.  Enhancer elements.

Authors:  G Khoury; P Gruss
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

5.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

6.  Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice.

Authors:  R Michalides; E Wagenaar; J Hilkens; J Hilgers; B Groner; N E Hynes
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus.

Authors:  J K Ball; H Diggelmann; G A Dekaban; G F Grossi; R Semmler; P A Waight; R F Fletcher
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  Glucocorticoid regulation of mouse mammary tumor virus: identification of a short essential DNA region.

Authors:  E Buetti; H Diggelmann
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  15 in total

Review 1.  Factors controlling the expression of mouse mammary tumour virus.

Authors:  W H Günzburg; B Salmons
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Stably integrated mouse mammary tumor virus long terminal repeat DNA requires the octamer motifs for basal promoter activity.

Authors:  E Buetti
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

3.  Ku antigen-DNA conformation determines the activation of DNA-dependent protein kinase and DNA sequence-directed repression of mouse mammary tumor virus transcription.

Authors:  W Giffin; W Gong; C Schild-Poulter; R J Haché
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  Altered mouse mammary tumor virus transcript synthesis in T-cell lymphoma cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Conversion of mouse mammary tumor virus to a lymphomagenic virus.

Authors:  Sanchita Bhadra; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.

Authors:  S Yanagawa; A Murakami; H Tanaka
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.

Authors:  J A Mertz; F Mustafa; S Meyers; J P Dudley
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene.

Authors:  C L Miller; R Garner; V Paetkau
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

9.  Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat.

Authors:  Francoise Rouault; Shiva Badihi Nejad Asl; Stefanie Rungaldier; Eva Fuchs; Brian Salmons; Walter H Günzburg
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

10.  Expression pattern of mouse mammary tumor virus in transgenic mice carrying exogenous proviruses of different origins.

Authors:  P Rollini; J Billotte; E Kolb; H Diggelmann
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.